wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26764934-A6409B60-7C69-4FC8-9796-A10DB62AEA5D
Q26764934-A6409B60-7C69-4FC8-9796-A10DB62AEA5D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26764934-A6409B60-7C69-4FC8-9796-A10DB62AEA5D
Advanced gastric cancer: Current treatment landscape and future perspectives
P2860
Q26764934-A6409B60-7C69-4FC8-9796-A10DB62AEA5D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26764934-A6409B60-7C69-4FC8-9796-A10DB62AEA5D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f3e13f31af3dfe9cd140d6dfe51418d7192f3230
P2860
A phase IIa dose-finding and safety study of first-line pertuzumab in combination with trastuzumab, capecitabine and cisplatin in patients with HER2-positive advanced gastric cancer